AOV.TO Amotiv Limited

Healthcare Pharmaceuticals Toronto Exchange
5.69 CAD
Close of Jul 8, 2024
5.66 11.89
Market cap
CAD 577M
P/E
-
P/B
0.77x
ROE
-0.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is AOV.TO undervalued?

Graham number

The Graham number of Amotiv Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Amotiv Limited fundamental analysis

No fundamental analysis for Amotiv Limited yet.

Amotiv Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Amotiv Limited

Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic ca…

Full company profile